Anti-ageing pills are real, and some of us are taking them without knowing it

Key Points:

• Emerging research suggests that drugs capable of slowing ageing, extending lifespan, and preventing age-related diseases may soon be available, with some already accessible as supplements or repurposed medications.
• Senolytic drugs, which target and eliminate senescent cells that accumulate with age and cause tissue damage, have shown promising results in animal studies, improving health and longevity even when administered late in life.
• Clinical trials, such as the ongoing TAME trial investigating metformin, aim to demonstrate whether these drugs can extend the healthspan in humans by delaying the onset of multiple age-related diseases rather than treating them individually.
• Challenges to anti-ageing drug development include the long timescales required for human ageing studies, regulatory hurdles in recognizing ageing as a treatable condition, and limited funding for trials of affordable, off-patent drugs.
• If successful, anti-ageing therapies could transform medical care from reactive treatment of diseases to proactive prevention, potentially improving quality of life for the growing elderly population and reducing healthcare costs globally.